This eBook summarizes several key technological decision points to guide institutions and companies along the path to clinic-ready, gene-edited MSCs. One of these major decisions involves the intracellular delivery modality for the gene editor and template. Learn how efficient transduction and transfection of gene editors into MSCs could prime your clinical pipeline with the next generation of cellular therapy candidates. Authored by Jon Carson, PhD, Strategic Marketing Manager.